SHANGHAI, Nov. 4, 2024
/PRNewswire/ -- United Imaging Healthcare (SSE: 688271), a global
leader in manufacturing advanced medical imaging and radiotherapy
equipment, announced its financial results for the third quarter of
2024. Reflecting its development strategy and strategic R&D
investments, the company reported that revenue of January to
September is 6.95 billion CNY, with
net income attributable to shareholders reaching 0.67 billion CNY.
In 2024, United Imaging Healthcare has significantly increased
its R&D efforts to pioneer high-end medical technologies and
support the digital transformation of healthcare institutions. To
date, over ten innovative United Imaging Healthcare products have
received market approval,* including:
- uLinac HalosTx, an integrated CT circular linear
accelerator
- uMI Panvivo, a robust new PET/CT platform
- uMI Panorama GS, a next-generation, 148cm whole-body PET/CT
system
- uOmnispace, a hospital-grade intelligent post-processing
software suite
These innovations, with the uMI Panorama molecular imaging
solution as a key highlight, have gained international recognition.
uMI Panorama has been installed at premier institutions in
the United States. And, at the
EANM 2024 the European Association of Nuclear Medicine (EANM)
annual congress, United Imaging Healthcare launched its
next-generation PET/CT system, the uMI Panvivo, which will be
unveiled for U.S. audiences at the Radiologic Society of
North America annual meeting in
Chicago, as part of an innovation
launch featuring multiple new products in several modalities.
Committed to advancing medical innovation through exceptional
R&D capabilities and industry leadership, United Imaging
Healthcare was recently honored on the Fortune China Tech
50 for 2024. This prestigious recognition underscores
United Imaging Healthcare's role in pioneering healthcare
technology and elevating standards in medical imaging and patient
care globally.
*not all products noted are clinically or commercially available
in the U.S.
About United Imaging Healthcare
At United Imaging Healthcare, we develop and produce advanced
medical products, digital healthcare solutions, and intelligent
solutions that cover the entire process of imaging diagnosis and
treatment. Founded in 2011, our company has subsidiaries and
R&D centers across China,
the United States, Poland, Dubai, and other parts of the world.
With a cutting-edge digital portfolio and a mission of Equal
Healthcare for All™, we help drive industry progress and bold
change. To learn more, visit https://www.united-imaging.com
View original
content:https://www.prnewswire.com/news-releases/united-imaging-healthcare-announces-q3-2024-results-with-revenue-of-january-to-september-of-6-95-billion-cny-302295094.html
SOURCE United Imaging Healthcare Co., Ltd.
